Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Hypofractionated Stereotactic Radiotherapy in Patients With Hepatocellular Carcinoma

NCT00607828 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00607828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00607828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Hypofractionated Stereotactic Radiotherapy in Patients With Hepatocellular Carcinoma
Lead sponsor
University of Nebraska
Phase
Not applicable
Overall status
Completed
Start date
November 16, 2007
Completion date
February 15, 2017
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer